Deal News

  • 13 February 2019

    Edwards Lifesciences to buy CASMED for $100m

    Edwards Lifesciences has signed a definitive agreement to acquire medical technology company CAS Medical Systems (CASMED) in an all-cash transaction valued at around $100m, or $2.45 per share.

Go Top